{"id":"W2078254962","doi":"10.1080/10428190290021632","title":"A Literature Review of Single Agent Treatment of Multiply Relapsed Aggressive Non-Hodgkin's Lymphoma","year":2002,"lang":"en","type":"review","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Vinorelbine; Etoposide; Oncology; Population; Internal medicine; Clinical trial; Lymphoma; Aggressive lymphoma; Vincristine; Inclusion and exclusion criteria; Rituximab; Chemotherapy; Pathology; Alternative medicine; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001086332,0.0007341639,0.002431115,0.004253688,0.0003287353,0.000822957,0.001147812,0.0007094226,0.003404293],"category_scores_gemma":[0.002449046,0.0003022605,0.0008376122,0.007138912,0.0003341056,0.001205984,0.0003597962,0.0004440258,0.0005650524],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007441363,"about_ca_system_score_gemma":0.001981209,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001814527,"about_ca_topic_score_gemma":0.004320048,"domain_scores_codex":[0.9993321,0.0001877586,0.0002302262,0.00008268856,0.0001433247,0.00002385319],"domain_scores_gemma":[0.9985252,0.0009588908,0.0002487948,0.00002552264,0.0002009243,0.00004064404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002503369,0.00006960972,0.000410897,0.2589789,0.000517622,0.00103573,0.0001804627,0.0002801401,0.0009374729,0.0004915196,0.01291432,0.723933],"study_design_scores_gemma":[0.0002924113,0.00127075,0.0126286,0.2353308,0.008730543,0.01588154,0.0006801421,0.0003631457,0.002176984,0.001626847,0.7209285,0.0000895982],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003307558,0.9991579,0.0000522332,0.00005360182,0.00005308329,0.0000123795,0.00002366452,0.000003671437,0.0003126827],"genre_scores_gemma":[0.001565767,0.9978994,0.0002451069,0.0001056319,0.00004446097,0.00001450802,0.00003335465,8.962094e-7,0.00009084],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004253688,"threshold_uncertainty_score":0.01138848,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02892763173816297,"score_gpt":0.2899046831440661,"score_spread":0.2609770514059031,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}